Literature DB >> 21075057

Meningococcal carriage by age: a systematic review and meta-analysis.

Hannah Christensen1, Margaret May, Leah Bowen, Matthew Hickman, Caroline L Trotter.   

Abstract

BACKGROUND: Neisseria meningitidis is an important cause of meningitis and septicaemia, but most infected individuals experience a period of asymptomatic carriage rather than disease. Previous studies have shown that carriage rates vary by age and setting; however, few have assessed carriage across all ages. We aimed to estimate the age-specific prevalence of meningococcal carriage.
METHODS: We searched Embase, Medline, Web of Science, the Cochrane Library, and grey literature for papers reporting carriage of N meningitidis in defined age groups in European countries or in countries with a similar epidemiological pattern (where disease caused by serogroups B and C predominates). We used mixed-effects logistic regression with a natural cubic spline to model carriage prevalence as a function of age for studies that were cross-sectional or serial cross-sectional. The model assessed population type, type of swab used, when swabs were plated, use of preheated plates, and time period (decade of study) as fixed effects, with country and study as nested random effects (random intercept).
FINDINGS: Carriage prevalence increased through childhood from 4·5% in infants to a peak of 23·7% in 19-year olds and subsequently decreased in adulthood to 7·8% in 50-year olds. The odds of testing positive for carriage decreased if swabs were not plated immediately after being taken compared with if swabs were plated immediately (odds ratio 0·46, 95% CI 0·31-0·68; p = 0·0001).
INTERPRETATION: This study provides estimates of carriage prevalence across all ages, which is important for understanding the epidemiology and transmission dynamics of meningococcal infection. FUNDING: None.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21075057     DOI: 10.1016/S1473-3099(10)70251-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  203 in total

1.  Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction.

Authors:  David A Ishola; Ray Borrow; Helen Findlow; Jamie Findlow; Caroline Trotter; Mary E Ramsay
Journal:  Clin Vaccine Immunol       Date:  2012-05-30

2.  Genetic characteristics of Neisseria meningitidis serogroup B strains carried by adolescents living in Milan, Italy: implications for vaccine efficacy.

Authors:  Susanna Esposito; Alberto Zampiero; Leonardo Terranova; Valentina Montinaro; Alessia Scala; Valentina Ansuini; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2013-07-23       Impact factor: 3.452

3.  Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.

Authors:  Heidi M Soeters; Melissa Whaley; Nicole Alexander-Scott; Koren V Kanadanian; Jessica R MacNeil; Stacey W Martin; Lucy A McNamara; Kenneth Sicard; Cynthia Vanner; Jeni Vuong; Xin Wang; Utpala Bandy; Manisha Patel
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

Review 4.  Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control.

Authors:  Paul Balmer; Laura J York
Journal:  Ther Adv Vaccines Immunother       Date:  2018-06-21

Review 5.  Review of meningococcal vaccines with updates on immunization in adults.

Authors:  Yorgo C Zahlanie; Moza M Hammadi; Soha T Ghanem; Ghassan S Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

6.  Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.

Authors:  Roberto Gasparini; Maurizio Comanducci; Daniela Amicizia; Filippo Ansaldi; Paola Canepa; Andrea Orsi; Giancarlo Icardi; Emanuela Rizzitelli; Gabriella De Angelis; Stefania Bambini; Monica Moschioni; Sara Comandi; Isabella Simmini; Giueseppe Boccadifuoco; Brunella Brunelli; Marzia Monica Giuliani; Mariagrazia Pizza; Donatella Panatto
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

7.  Epidemiology of infant meningococcal disease in the United States, 2006-2012.

Authors:  Jessica R MacNeil; Nancy Bennett; Monica M Farley; Lee H Harrison; Ruth Lynfield; Megin Nichols; Sue Petit; Arthur Reingold; William Schaffner; Ann Thomas; Tracy Pondo; Leonard W Mayer; Thomas A Clark; Amanda C Cohn
Journal:  Pediatrics       Date:  2015-01-12       Impact factor: 7.124

Review 8.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

9.  Full Molecular Typing of Neisseria meningitidis Directly from Clinical Specimens for Outbreak Investigation.

Authors:  Mark Itsko; Adam C Retchless; Sandeep J Joseph; Abigail Norris Turner; Jose A Bazan; Adodo Yao Sadji; Rasmata Ouédraogo-Traoré; Xin Wang
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

10.  Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom.

Authors:  Maheshi N Ramasamy; Elizabeth A Clutterbuck; Kathryn Haworth; Jaclyn Bowman; Omar Omar; Amber J Thompson; Geraldine Blanchard-Rohner; Ly-Mee Yu; Matthew D Snape; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2014-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.